Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

Scientists search for cystitis pain 'off switch'

By targeting certain pain receptors in the bladder, Australian scientists believe that the...

Australia's first cases of H5 avian influenza confirmed

Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...

AusBiotech partners with Tenmile

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

Content from other channels on our network

Analysis shows AI's water use demands immediate action

New method recycles mixed plastic packaging sans chemicals

Microbubbles remove microplastics from wastewater

Partnership boosts bio-based graphite material deployment

New way to recycle coloured plastics using silica microspheres

Steelmaking returning to Newcastle with Greensteel Australia

AMCRC announces project to evaluate local titanium powder

NSW to invest $12bn to rebuild Hunter train manufacturing

Orica hydrogen hub project reaches major investment milestone

Dual-bubble method removes more microplastics from wastewater

National standards for pain management education now available

Daniel Wyner appointed Lumary CEO

Home care safeguards when disasters hit

"Historic legislation" allows authorised nurses to prescribe PBS medicines

You see what others miss